SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001640334-23-001495
Filing Date
2023-08-09
Accepted
2023-08-09 12:35:41
Documents
1
Period of Report
2023-08-08

Document Format Files

Seq Description Document Type Size
1 PRE 14A lxrp_pre14a.htm PRE 14A 166349
  Complete submission text file 0001640334-23-001495.txt   167517
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: PRE 14A | Act: 34 | File No.: 001-39874 | Film No.: 231154278
SIC: 2834 Pharmaceutical Preparations